Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: a Randomized Controlled Study -DALFEN Study

NCT03003273 is registered in ClinicalTrials.gov with All India Institute of Medical Sciences as lead sponsor.

NCT NCT03003273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03003273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: a Randomized Controlled Study -DALFEN Study
Lead sponsor
All India Institute of Medical Sciences
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2017
Completion date
December 31, 2018
Enrollment
142 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neutropenia, febrile, pediatric cancer